APA aipamena

Yin, S., Kaluz, S., Devi, N. S., Jabbar, A. A., de Noronha, R. G., Mun, J., . . . Van Meir, E. G. (2012). Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with co-factors p300/CBP.

Chicago Style aipamena

Yin, Shaoman, et al. Arylsulfonamide KCN1 Inhibits in Vivo Glioma Growth and Interferes With HIF Signaling By Disrupting HIF-1α Interaction With Co-factors P300/CBP. 2012.

MLA aipamena

Yin, Shaoman, et al. Arylsulfonamide KCN1 Inhibits in Vivo Glioma Growth and Interferes With HIF Signaling By Disrupting HIF-1α Interaction With Co-factors P300/CBP. 2012.